Cargando…
CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells
Fanconi anemia (FA) is an inherited condition characterized by impaired DNA repair, physical anomalies, bone marrow failure, and increased incidence of malignancy. Gene editing holds great potential to precisely correct the underlying genetic cause such that gene expression remains under the endogen...
Autores principales: | Skvarova Kramarzova, Karolina, Osborn, Mark J., Webber, Beau R., DeFeo, Anthony P., McElroy, Amber N., Kim, Chong Jai, Tolar, Jakub |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486091/ https://www.ncbi.nlm.nih.gov/pubmed/28613254 http://dx.doi.org/10.3390/ijms18061269 |
Ejemplares similares
-
CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa
por: Webber, Beau R, et al.
Publicado: (2016) -
CRISPR/Cas9-Based Cellular Engineering for Targeted Gene Overexpression
por: Osborn, Mark J., et al.
Publicado: (2018) -
Engineering CRISPR/Cas9 for Multiplexed Recombinant Coagulation Factor Production
por: Feser, Colby J., et al.
Publicado: (2022) -
CRISPR/Cas9-Based Lateral Flow and Fluorescence Diagnostics
por: Osborn, Mark J., et al.
Publicado: (2021) -
Genome-wide Specificity of Highly Efficient TALENs and CRISPR/Cas9 for T Cell Receptor Modification
por: Knipping, Friederike, et al.
Publicado: (2017)